Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-24 Purchase |
2021-11-29 08:00 am |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,780 | $79.33 | $299,867 | 65,678 (Direct) |
View |
| 2021-11-17 Purchase |
2021-11-17 6:24 pm |
Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S President & CEO |
25,026 | $79.94 | $2,000,578 | 365,082 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-10 8:04 pm |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,000 | $85.76 | $428,800 | 140,517 (Indirect Direct) |
View |
| 2021-03-08 Sale |
2021-03-10 8:03 pm |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,000 | $83.51 | $835,100 | 16,518 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-07 Option Award |
2022-03-08 8:06 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | GRAY MARY ANN Director |
8,030 | $0 | 17,433 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:05 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
8,030 | $0 | 24,548 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:04 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
8,030 | $0 | 153,547 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:03 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
8,030 | $0 | 3,133,396 (Direct) |
View |
| 2022-03-07 Tax Withholding |
2022-03-08 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
398 | $79.36 | 80,671 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,308 | $79.2 | 80,671 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:02 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
56,000 | $0 | 80,671 (Direct) |
View |
| 2022-03-07 Tax Withholding |
2022-03-08 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
153 | $79.36 | 73,895 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
1,136 | $79.2 | 73,895 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:02 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
56,000 | $0 | 73,895 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Ciambrone William EVP |
1,160 | $79.2 | 70,099 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:01 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Ciambrone William EVP |
56,000 | $0 | 70,099 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,216 | $79.2 | 120,111 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-08 8:00 pm |
2023-03-07 2032-03-07 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
56,000 | $0 | 120,111 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-01 8:03 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
572 | $75.05 | 65,327 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-01 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
376 | $75.05 | 26,377 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-01 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
184 | $75.05 | 19,184 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-16 8:00 pm |
2013-08-23 2022-08-23 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,000 | $0 | 145,517 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-16 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,000 | $10.08 | 145,517 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 8:02 pm |
2021-12-10 N/A |
Sarepta Therapeutics Inc. | SRPT | GRAY MARY ANN Director |
967 | $0 | 9,403 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-17 8:06 pm |
2022-11-16 2031-11-16 |
Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-17 8:03 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
40,000 | $0 | 61,898 (Direct) |
View |
| 2021-09-08 Tax Withholding |
2021-09-09 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,623 | $78.29 | 26,753 (Direct) |
View |
| 2021-06-26 Tax Withholding |
2021-06-28 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S President & CEO |
17,812 | $80.4 | 340,056 (Direct) |
View |
| 2021-06-01 Tax Withholding |
2021-06-03 4:57 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
64 | $76.01 | 19,368 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-10 8:04 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,000 | $42.3 | 140,517 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-10 8:04 pm |
2012-06-21 2021-06-21 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,000 | $0 | 140,517 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 8:03 pm |
2014-06-04 2023-06-04 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,000 | $0 | 16,518 (Direct) |
View |
| 2021-03-08 Exercise |
2021-03-10 8:03 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,000 | $34.92 | 16,518 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
524 | $86.97 | 28,546 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
15,000 | $0 | 28,546 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
216 | $86.97 | 19,432 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
15,000 | $0 | 19,432 (Direct) |
View |
| 2021-03-04 Tax Withholding(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
190 | $80.76 | 19,432 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
565 | $86.97 | 21,780 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:01 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
15,000 | $0 | 21,780 (Direct) |
View |
| 2021-03-05 Tax Withholding(A) |
2021-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
347 | $84.65 | 28,376 (Direct) |
View |
| 2021-02-28 Tax Withholding(A) |
2021-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
319 | $86.97 | 28,376 (Direct) |
View |
| 2021-03-03 Option Award(A) |
2021-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
15,000 | $0 | 28,376 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:06 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
8,244 | $0 | 22,036 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:05 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer |
75,000 | $0 | 82,169 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:05 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | O'Neill Gilmore Neil EVP, R&D & CMO |
75,000 | $0 | 89,070 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:04 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
8,244 | $0 | 17,370 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:04 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | MARTIN JOHN C Director |
8,244 | $0 | 13,431 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:03 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | GRAY MARY ANN Director |
8,244 | $0 | 13,954 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:03 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
75,000 | $0 | 89,042 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:02 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Ciambrone William EVP |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:02 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
75,000 | $0 | 79,838 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:01 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
8,244 | $0 | 3,130,884 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 8:00 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
8,244 | $0 | 146,035 (Direct) |
View |
Ownership |
2021-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel |
0 | $0 | 38,093 (Direct) |
View |
| 2020-08-10 Ownership |
2021-02-12 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
6,500 | $0 | 3,122,640 (Direct) |
View |